MONMOUTH JUNCTION, N.J., Oct. 7 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced the US Food and Drug Administration (FDA) has approved first-ever generic of TUSSIONEX®, an Extended-Release Suspension containing hydrocodone polistirex and chlorpheniramine polistirex.
